Clinical Trial Update: Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric Surgery [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating bisphosphonates to mitigate bone loss following bariatric surgery; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Loss

Drugs mentioned

• Bisphosphonate

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Bone Loss | Phase 3 | Status: RECRUITING